Abstract:AIM: To evaluate the efficacy of itraconazole injection and oral solution for the treatment of central nervous system ( CNS) fungal infection, and its safety in combination with amphotericin B, and/or flucytosine. METHODS: Seventeen patients admitted to our hospital with CNS fungal infection were enrolled in an open-label clinical trial from June 2004 to September 2005. They were treated with itraconazole alone or combined with amphotericine B, and/or flucytosine. In this study, patients were treated with itraconazole injection (d 1 - 2, 200 mg, q 12 h; d 3 - 14, 200 mg·d-1) for a minimum of 7 d were included in the efficacy eval- After treated with intraconazole injection, the patients were followed by administration of intraconazole oral solution, and/or in combination with amphotericine B slow intravenouse infusion or flucytosine taken orally. RESULTS: A total of 17 patients included definite (n = 14) or probable (n = 3) CNS fungal infection were enrolled. The identified fungi were Cryptococcus neoformans, Aspergillus spp., and Prototheca wickerhamii. All the patients had headache, fever, and higher than 300 mmH2O intracranial pressure, including 7 patients with underlying diseases, 7 patients with complication of coma and 10 patients with cerebral herniation. Six patients underwent Ommaya-reservoir and ventricular shunt operations. Overall, two patients died at 2 d after the therapy excluding from the efficacy evaluation. The rest 15 patients included 11 (11/15, 73%) with excellent response to this remedy consisting of one with cerebral aspergilloma, one with aspergillus meningitis, one with prototheca wickerhamii meningitis, two with cerebral cryptococcoma, and six with cryptococcal meningitis, only three of them were treated with itraconazole alone. Three patients with cryptococcal meningitis showed partial response and one failed. All patients tolerated well with itraconazole. The adverse reactions including only 2 of mild liver function disorder probably due to intravenous administration and 3 of mild to moderate nausea, loss of appetite after oral intake more than 2 mo. CONCLUSION: Itraconazole injection and oral solution show impressive curing activity on CNS fungal infection together with safety on either itraconazole alone or combined with other antifungal drugs (amphotericine B, and/or flucytosine) .

Intraconazol injection for treatment of fungal infections in 51 patients with malignant hematologic diseases

Efficacy and Safety of Itraconazole on Invasive Fungal Infections in 66 Patients with Malignant Hematological Diseases

Efficacy and Safety of Itraconazole As Empirical Antifungal Therapy in Febrile Neutropenic Patients with Hematologic Malignancies: an Open-Lable, Multicenter, Observational Trial in A Chinese Cohort

Efficacy of intravenous itraconazole on invasive fungal infections in patients with hematological malignancies

Efficacy And Predictive Factors Of Intravenous Itraconazole Empirical Treatment For Patients With Hematological Malignancies Suspected Of Invasive Fungal Disease

Efficacy of Itraconazole on Invasive Fungal Infections with Malignant Hematologic diseases

A Retrospective Study of Efficacy and Safety of Itraconazole for Treatment of Invasive Fungal Infection in Hematologic Diseases

Itraconazole Treatment in Fungal Infection in the Patients with Hematological Malignancies

[Efficacy of Intravenous Administration of Itraconazole on Fungal Infections in Immunocompromised Patients with Hematological Diseases].

Utility of intraconazole in treatment of invasive fungal infections of haematological patients

Efficacy and safety of itraconazole injection in treatmeat of deep fungal infecfions

Itraconazole Injection/oral Solution Therapy for Central Nervous System Fungal Infection: an Open Clinical Study

[Itraconazole for Treatment of Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation].

Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in China

Meta-analysis of Therapeutic Efficacy of Itraconazole Against Invasive Fungal Infection in Hematology Patients

[Efficacy and Safety of Intravenous Itraconazole in Different Antifungal Strategies for Patients Undergoing Intensive Chemotherapy or Hematopoietic Stem Cell Transplantation].

[An Analysis of Efficacy and Related Factors of Itraconazole in the Treatment of Invasive Fungal Infection in Hematological Diseases].

[The Clinical Study of Invasive Fungal Infection in 76 Cases of Hematologic Diseases].

Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients A retrospective observational study

Study on efficacy and safety of itraconazole in treatment of pulmonary fungal infections in elderly patients

Clinical analysis on the effect of itraconazole oral solution versus fluconazole in the prevention of fungal infection in neutropenic patients with acute leukemia